Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

New Module Enables Super-Resolution Microscopy of Cell Organelles in Three Dimensions

By BiotechDaily International staff writers
Posted on 20 Nov 2013
Image: The ELYRA super-resolution microscope system enables 3D-PALM imagery (Photo courtesy of Zeiss).
Image: The ELYRA super-resolution microscope system enables 3D-PALM imagery (Photo courtesy of Zeiss).
Biotech researchers and other life scientists who employ advanced microscopy techniques are now able to move up to a state-of-the-art super-resolution microscopy system.

Zeiss (Jena, Germany) has introduced ELYRA P.1, a new module that makes possible three-dimensional (3D) super-resolution photoactivated localization microscopy (PALM) for endogenously-expressed photo-switchable fluorescent proteins.

In PALM, photo-switchable fluorescent molecules are sparsely activated so that only one out of many will be in its on-state within a single point spread function (PSF). In 3D, the PSF shape codes for the z-position. The localizations are plotted in a new image to create the super-resolved image. ELYRA P.1 achieves resolutions in the range of 20–30 nanometers laterally and 50–80 nanometers axially. The ELYRA P.1 module captures highly resolved structures in 3D, while treating the sample so gently that it remains available for long-term observation.

The ELYRA system can be integrated with the Zeiss laser scanning microscopes LSM 710 or LSM 780. In addition, ELYRA works seamlessly together with Zeiss scanning electron microscopes.

“With ELYRA, researchers can investigate the structural arrangement of one or multiple proteins, reveal the ultrastructure of cell organelles in 2D and 3D as well as map and count molecules within a structure. Sophisticated algorithms relate photon statistics to precision information in all directions, so researchers can display their structures fully rendered in 3D,” said Dr. Klaus Weisshart, ELYRA product manager at Zeiss.

Related Links:

Zeiss



Channels

Genomics/Proteomics

view channel
Image: Typical antibodies (left) unfold in the harsh environment of the cell. Camelid antibodies (right) are smaller and more stable (Photo courtesy of the Washington University School of Medicine).

Double Targeting Approach Increases Potential for Cancer Treatment with Oncolytic Viruses

Cancer researchers have used a double targeting approach to direct oncolytic viruses specifically to tumor cells where they reproduce until the cancer cells burst, releasing more viruses to infect and... Read more

Drug Discovery

view channel
Image: Molecular model of the protein Saposin C (Photo courtesy of Wikimedia Commons).

Nanovesicles Kill Human Lung Cancer Cells in Culture and in a Mouse Xenograft Model

Nanovesicles assembled from the protein Saposin C (SapC) and the phospholipid dioleoylphosphatidylserine (DOPS) were shown to be potent inhibitors of lung cancer cells in culture and in a mouse xenograft model.... Read more

Biochemistry

view channel

Possible New Target Found for Treating Brain Inflammation

Scientists have identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited eurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that suppress this enzyme.... Read more

Business

view channel

Roche Acquires Signature Diagnostics to Advance Translational Research

Roche (Basel, Switzerland) will advance translational research for next generation sequencing (NGS) diagnostics by leveraging the unique expertise of Signature Diagnostics AG (Potsdam, Germany) in biobanks and development of novel NGS diagnostic assays. Signature Diagnostics is a privately held translational oncology... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.